Literature DB >> 7053570

Origin of the cholecystokinin-containing fibers in the rat caudatoputamen.

D K Meyer, M C Beinfeld, W H Oertel, M J Brownstein.   

Abstract

Large Amounts of cholecystokinin-octapeptide (CCK) are present in the rat caudatoputamen. The peptide occurs in axons and nerve endings but not in perikarya. The origin of CCK in the caudatoputamen was investigated with the use of immunocytochemistry and a radioimmunoassay specific for CCK. Although a small amount of CCK (approximately 30 percent) originates in the amygdaloid complex, the bulk of the peptide (approximately 70 percent) occurs in processes of neurons located ventral to the caudatoputamen, that is, the claustrum or the piriform cortex. The claustrum and piriform cortex receive inputs from various cortical areas and the olfactory system, respectively, and may process information and relay it to the caudatoputamen. Thus CCK may by the transmitter in the final common pathway linking various cortical areas and the olfactory system to the caudatoputamen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053570     DOI: 10.1126/science.7053570

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  11 in total

1.  Proceedings of the British Pharmacological Society Meeting. Sheffield, 18-20th April 1990.

Authors: 
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

2.  Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens.

Authors:  Joshua T Morra; Stanley D Glick; Joseph F Cheer
Journal:  Neuropharmacology       Date:  2012-05-15       Impact factor: 5.250

3.  Blockade of gamma-aminobutyric acid-receptors of the B-subtype inhibits the dopamine-induced enhancement of the release of cholecystokinin-like immunoreactivity from slices of rat dorsal caudatoputamen.

Authors:  U Conzelmann; D K Meyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

4.  Stimulation of receptors of gamma-aminobutyric acid modulates the release of cholecystokinin-like immunoreactivity from slices of rat neostriatum.

Authors:  U Conzelmann; D K Meyer; G Sperk
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

5.  Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons.

Authors:  N Lindefors; S Brené; M Herrera-Marschitz; H Persson
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

6.  Functional role for vasoactive intestinal polypeptide in the caudate nucleus: a 2-deoxy[14C]glucose investigation.

Authors:  J McCulloch; P A Kelly; R Uddman; L Edvinsson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  Simultaneous determination of cholecystokinin, dopamine, glutamate and aspartate in cortex and striatum of the rat using in vivo microdialysis.

Authors:  J J Meana; M Herrera-Marschitz; E Brodin; T Hökfelt; U Ungerstedt
Journal:  Amino Acids       Date:  1991-10       Impact factor: 3.520

8.  Few cortical cholecystokinin immunoreactive neurons have long projections.

Authors:  K B Seroogy; J H Fallon; S E Loughlin; F M Leslie
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

9.  Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats.

Authors:  Z B You; T M Tzschentke; E Brodin; R A Wise
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

Review 10.  Neuropeptides in dopamine-containing regions of the brain.

Authors:  A Albanese; M C Altavista
Journal:  Ital J Neurol Sci       Date:  1984-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.